Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tesaro appoints new board member

This article was originally published in Scrip

Executive Summary

Oncology-focused biopharmaceutical company, Tesaro, has appointed Dr James Armitage to its board of directors – increasing the number of independent directors on the board to six. Dr Armitage is currently the Joe Shapiro chair for the study of oncology and clinical research at the University of Nebraska Medical Center, Omaha. He has also served as president of the American Society of Clinical Oncology and the American Society for Blood and Marrow Transplantation.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC021343

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel